ITW Dr. Fred Jordan, CEO of FinalSpark!

Swiss Startup Revolutionizing AI with Human Neurons. 🧠into🤖

The Future of Computing is Here and Alive: Join the FinalSpark Revolution

FinalSpark, a Swiss startup, is pioneering biocomputing by leveraging living neurons to develop advanced computational systems. Led by visionary Dr. Fred Jordan, FinalSpark cultivates human-derived neuro-organoids that mimic the brain and connects them to in silico systems.

Biocomputers could be a million times more energy-efficient than traditional AI, reducing environmental impact.

FinalSpark's groundbreaking platform is already used by 9 universities globally for cutting-edge biocomputing research. However, scaling up requires overcoming challenges like growing and maintaining large neuron networks.

The team behind FinalSpark is as impressive as its vision. Dr. Fred Jordan and Dr. Martin Kutter are joined by a diverse group of experts, including biologists, engineers, and advisors with decades of experience. This multidisciplinary approach ensures that FinalSpark is not just a tech company but a hub of innovation where different fields converge to create something extraordinary.

This is an opportunity to be part of a revolution:

Deep tech investors: FinalSpark is ready to accelerate R&D in this potentially world-changing technology.

Neurobiologists: Contribute to pioneering research bridging biology and tech by collaborating on FinalSpark's work with hippocampal organoids and memory.

Technologists: With open access and Python programmability, FinalSpark's platform offers a playground for innovation in algorithms, models, and more.

The FinalSpark adventure demands vision, collaboration and pushing boundaries. Are you ready to join and create a future where machines think and learn?

----

Co-host: Dr. Benjamin DELSOL, Quantum Physicist, European Patent Attorney, Expert Deep Tech Innovation / DELSOL

Hosted on Acast. See acast.com/privacy for more information.

Découvrez l'Art de la Communication Efficace avec Audrey Degail, experte en Process Communication Model (PCM). Fondatrice de LINE, elle accompagne les entreprises et leurs équipes pour optimiser leur communication. Dans cet épisode d'E², Audrey partage son parcours inspirant, marqué par une expérience dans le secteur public et une quête de sens et de liberté.

Elle découvre alors le PCM, un outil puissant développé par le Dr. Taibi Kahler, initialement utilisé par la NASA. Il permet de comprendre et d'améliorer les interactions humaines en identifiant les types de personnalités et leurs modes de communication. Pour Audrey, c'est un effet 'waouh', une révélation sur elle-même et les autres.

Elle souligne l'importance de la communication interpersonnelle, différente selon les cultures. En France, elle est souvent vue comme unidirectionnelle, alors qu'aux États-Unis, elle est perçue comme un échange interactif. Audrey insiste sur le fait que la communication efficace nécessite que les deux parties soient sur le même canal.

Le PCM est utilisé par Audrey pour aider les entreprises à améliorer leur communication interne, que ce soit pour résoudre des conflits ou faciliter les transitions. C'est aussi un outil de développement personnel, permettant de mieux se comprendre et comprendre les autres.

Rencontrer Audrey et découvrir le PCM est une expérience enrichissante. Son parcours et sa passion pour la communication sont contagieux. Si vous êtes intéressé par l'amélioration de vos compétences en communication, nous vous encourageons à explorer le PCM. Pour en savoir plus sur Audrey et le PCM, suivez ses interventions.

Audrey Degail | LinkedIn

LINE I workshops I associés I degail I bordeaux (just-line.fr)

Livres recommandés par Audrey

PCM en interaction : Se connecter à soi-même et aux autres (Accompagnement et Coaching)

https://amzn.eu/d/bCFBmO6

L'Intelligence intime

https://amzn.eu/d/8P8GX1A

Le podcast de Maud Ankaoua recommandé par Audrey

https://www.maud-ankaoua.com/podcast.php

Hosted on Acast. See acast.com/privacy for more information.

Unveiling the Secrets of Aging: An Exclusive Interview with Dr. Michael Fossel

This article presents a captivating conversation with Dr. Michael Fossel, a leading expert in aging biology. Co-hosted by Gabriel Cian, the discussion delved into telomere biology, aging research, and medical science's future.

Dr. Fossel's Career: Aging and Telomeres

With a PhD in neurobiology and a Medical Doctorate, Dr. Fossel has dedicated his career to understanding and potentially reversing aging. His work on cellular senescence and telomere shortening has been pivotal. As Telocyte's founder, he's spearheading telomere therapy clinical trials to combat age-related diseases.

From Early Life to Scientific Pursuits

Despite his parents' intelligence backgrounds, Dr. Fossel's fascination with science emerged in high school, initially through mathematics and physics, then psychology and neurobiology. A significant moment at Stanford led him to medical school, where he questioned prevailing views on aging.

Understanding Aging: The Elephant in the Room

Dr. Fossel likens our fragmented understanding of aging to the "blind man and the elephant." He emphasizes that we often fail to see the bigger picture, which led him to clinical medicine, finding emotional satisfaction in improving patients' lives and intellectually understanding age-related diseases.

Telomeres and Telomerase: The Breakthrough

The 1990s were a turning point for Dr. Fossel, with the discovery of telomeres and telomerase providing a cohesive framework to understand aging. This led to his book, "Reversing Human Aging," laying the foundation for future research and potential therapies.

Aging: A Practical Approach

Dr. Fossel's pragmatic approach to aging is inspiring. He argues that the real question is not whether aging is a disease, but what we can do about it. His focus is on alleviating the pain, discomfort, and fear associated with age-related diseases.

Future of Aging Research

Dr. Fossel emphasizes the importance of understanding aging's underlying mechanisms to develop effective interventions. His work with Telocyte aims to translate this knowledge into practical therapies, improving millions' quality of life.

In conclusion, this interview with Dr. Fossel was a profound exploration of aging science, filled with personal anecdotes, scientific insights, and a clear vision for the future. It underscores the importance of interdisciplinary research and a holistic understanding of aging

Michael Fossel | LinkedIn

Telocyte | A future beyond Alzheimer's

Amazon.com: Michael Fossel: books, biography, latest update

---

Gabriel Cian | LinkedIn

What if you could add 10 more years in good health ? (ikare.ai)

2060.life – The Shortest Path to Indefinite Lifespan

Ari Massoudi | LinkedIn

Hosted on Acast. See acast.com/privacy for more information.